Literature DB >> 20548807

Update on lipids and C-reactive protein in acute and chronic coronary heart disease.

Peter H Jones1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20548807      PMCID： PMC2879197     

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN： 0730-2347


× No keyword cloud information.
  8 in total

Review 1.  Lipoprotein management in patients with cardiometabolic risk: consensus statement from the American Diabetes Association and the American College of Cardiology Foundation.

Authors:  John D Brunzell; Michael Davidson; Curt D Furberg; Ronald B Goldberg; Barbara V Howard; James H Stein; Joseph L Witztum
Journal:  Diabetes Care       Date:  2008-04       Impact factor: 19.112

2.  Novel approaches for preventing or limiting events (Naples) II trial: impact of a single high loading dose of atorvastatin on periprocedural myocardial infarction.

Authors:  Carlo Briguori; Gabriella Visconti; Amelia Focaccio; Bruno Golia; Alaide Chieffo; Alfredo Castelli; Marco Mussardo; Matteo Montorfano; Bruno Ricciardelli; Antonio Colombo
Journal:  J Am Coll Cardiol       Date:  2009-08-06       Impact factor: 24.094

3.  Effects of combination lipid therapy in type 2 diabetes mellitus.

Authors:  Henry N Ginsberg; Marshall B Elam; Laura C Lovato; John R Crouse; Lawrence A Leiter; Peter Linz; William T Friedewald; John B Buse; Hertzel C Gerstein; Jeffrey Probstfield; Richard H Grimm; Faramarz Ismail-Beigi; J Thomas Bigger; David C Goff; William C Cushman; Denise G Simons-Morton; Robert P Byington
Journal:  N Engl J Med       Date:  2010-03-14       Impact factor: 91.245

4.  Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.

Authors:  Paul M Ridker; Eleanor Danielson; Francisco A H Fonseca; Jacques Genest; Antonio M Gotto; John J P Kastelein; Wolfgang Koenig; Peter Libby; Alberto J Lorenzatti; Jean G MacFadyen; Børge G Nordestgaard; James Shepherd; James T Willerson; Robert J Glynn
Journal:  N Engl J Med       Date:  2008-11-09       Impact factor: 91.245

5.  Efficacy of atorvastatin reload in patients on chronic statin therapy undergoing percutaneous coronary intervention: results of the ARMYDA-RECAPTURE (Atorvastatin for Reduction of Myocardial Damage During Angioplasty) Randomized Trial.

Authors:  Germano Di Sciascio; Giuseppe Patti; Vincenzo Pasceri; Achille Gaspardone; Giuseppe Colonna; Antonio Montinaro
Journal:  J Am Coll Cardiol       Date:  2009-07-02       Impact factor: 24.094

6.  Genetically elevated C-reactive protein and ischemic vascular disease.

Authors:  Jeppe Zacho; Anne Tybjaerg-Hansen; Jan Skov Jensen; Peer Grande; Henrik Sillesen; Børge G Nordestgaard
Journal:  N Engl J Med       Date:  2008-10-30       Impact factor: 91.245

7.  Genetic Loci associated with C-reactive protein levels and risk of coronary heart disease.

Authors:  Paul Elliott; John C Chambers; Weihua Zhang; Robert Clarke; Jemma C Hopewell; John F Peden; Jeanette Erdmann; Peter Braund; James C Engert; Derrick Bennett; Lachlan Coin; Deborah Ashby; Ioanna Tzoulaki; Ian J Brown; Shahrul Mt-Isa; Mark I McCarthy; Leena Peltonen; Nelson B Freimer; Martin Farrall; Aimo Ruokonen; Anders Hamsten; Noha Lim; Philippe Froguel; Dawn M Waterworth; Peter Vollenweider; Gerard Waeber; Marjo-Riitta Jarvelin; Vincent Mooser; James Scott; Alistair S Hall; Heribert Schunkert; Sonia S Anand; Rory Collins; Nilesh J Samani; Hugh Watkins; Jaspal S Kooner
Journal:  JAMA       Date:  2009-07-01       Impact factor: 56.272

8.  C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis.

Authors:  Stephen Kaptoge; Emanuele Di Angelantonio; Gordon Lowe; Mark B Pepys; Simon G Thompson; Rory Collins; John Danesh
Journal:  Lancet       Date:  2009-12-22       Impact factor: 79.321
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.